TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Concentration required to reduce binding of fibrinogen (Fg) to alpha IIb beta3 integrin by 50%More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)